Fundz

Kubanda Cryotherapy, Inc. reported raising $100,000 in an initial SEC Form D filing, from an offering of $450,000

PRIVATEApr 02, 2021$100K of $450K raised

Amount Raised

$100,000

$100,000 sold, per SEC Form D (first sale Apr 2, 2021)

Round Type

Pre-Seed

BaltimoreBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Kubanda Cryotherapy, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Axtria raised $100M on May 17, 2021.
  • AssayQuant Technologies, Inc. raised $5.1M (Seed) on May 14, 2021.
  • GIOCOV Ltd raised an undisclosed amount on May 14, 2021.
  • Shifa Biomedical Corp raised $1.8M (Seed) on May 14, 2021.
  • Harrow raised $11M on May 14, 2021.
  • Vaxess Technologies raised $25M on May 14, 2021.

Who to call at Kubanda Cryotherapy, Inc., and when

A new round usually means Kubanda Cryotherapy, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kubanda Cryotherapy, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kubanda Cryotherapy, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kubanda Cryotherapy, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kubanda Cryotherapy, Inc.

Location

3600 CLIPPER MILL ROAD

Baltimore, Maryland, United States

About

We provide the first minimally invasive treatment for benign and malignant masses in pets. By revolutionizing cryotherapy -- used in human medicine for more than 60 years -- we’re bringing human-quality care to man’s best friends. Our novel CryoNeedle system uses focused extreme cold to quickly and easily treat tumors, letting pets skip the scalpel and get back to playtime. After six years of successful research and development, including clinical trials at Johns Hopkins Hospital -- we are now launching our treatment offerings to clinics everywhere!

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kubanda Cryotherapy, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBailey S., Executive Officer, Director, PromoterSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kubanda Cryotherapy, Inc.'s next move

See what Strategic adds

Kubanda Cryotherapy, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.